Serum prohepcidin levels are potential prognostic markers in patients with multiple myeloma
Prohepcidin is the prohormone of hepcidin. Anemia is one of the main clinical features in patients with multiple myeloma (MM) and hepcidin may be associated with iron homeostasis in these patients. However, the clinical significance of prohepcidin is not fully understood. In this retrospective study...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
D.A. Spandidos
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501378/ |